study suggested that nirmatrelvir-ritonavir (Paxlovid) and molnupiravir (Lagevrio) both reduced the risk " /> study suggested that nirmatrelvir-ritonavir (Paxlovid) and molnupiravir (Lagevrio) both reduced the risk " />

·¬ΗΡΙηΗψ

Preferred Drug for High-Risk COVID?

·¬ΗΡΙηΗψ MedicalToday

A study suggested that nirmatrelvir-ritonavir (Paxlovid) and molnupiravir (Lagevrio) both reduced the risk for COVID hospitalization or death during the Omicron era

What's best for high-risk patients?

    • Total Votes: 109
    ·¬ΗΡΙηΗψ Medical Today® surveys are polls of those who choose to participate and are, therefore, not valid statistical samples, but rather a snapshot of what your colleagues are thinking